In Episode 62 of Investing in Cannabis, Brandon David interviewed Marc Lustig, the CEO of CannaRoyalty (CSE: CRZ) (OTC: CNNRF), a Canadian company that is building a portfolio of brands and intellectual property. The company, which just raised $15mm by selling 5mm shares at $3 per share, has invested in drug delivery and extraction technologies. CannaRoyalty has now made 23 investments to date since its inception two years ago, and Lustig expects to make 7 additional investments in 2017.

Lustig explained the rationale for the company’s recent investment into Anandia Labs, which is based in Canada. He cited the management (including founders Jonathan Page and John Coleman) and the genetics work that it has done. Anandia Labs, according to Lustig, is the only testing lab in Canada dedicated exclusively to cannabis. Finally, he believes that their Dealer’s License is an unappreciated asset that opens the door potentially to being an extracts wholesaler and to get involved in imports/exports.

He also detailed the Rich Extracts deal that gives CannaRoyalty 30% of all sales in exchange for a $2.5mm investment that allowed it to build an extraction facility. Lustig said that he has a great reputation and has built the largest facility in Oregon at 30K sq. ft. The company tends to allow the companies in which it invests to operated independently, but it has acquired fully two companies that it has integrated including a marketing company (Electric Medialand) and a cartridge manufacturer (Dreamcatcher Labs).

Lustig believes that bigger investors are starting to come into the sector, making it a bit more competitive for the company to find more investments. He expects that the uncertainty about federal enforcement of the Controlled Substance Act will keep the really big players out. The company is investing in front of what it expects will be a tight window of time before Tobacco, Pharmaceutical, Nutraceutical and Consumer Products companies and funds make investments into the industry.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by Alan Brochstein, CFA Facebook | LinkedIn | Email Based in Houston, Alan leverages his experience as founder of online communities 420 Investor , the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures , he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha , where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter